How Race and Social Inequalities Influence Healthy People's Paid Participation in FDA-Required Clinical Trials
1.0 Ethics/DEI Credits
How Race and Social Inequalities Influence Healthy People’s Participation in FDA-Required Clinical Trials
Jill A. Fisher, Professor of Social Medicine at the University of North Carolina, Chapel Hill
Professor Fisher’s work explores how social inequalities are produced or exploited by commercialized medicine in the United States, especially in the conduct of clinical trials. Her talk will build on insights from her award-winning book, Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals.